Liver Cancer

New treatment reduces tumors and improves quality of life for patients

Published in Hepatitis Weekly, June 10th, 2002

A new treatment option for inoperable primary liver cancer called TheraSphere appears to be safe and effective for liver cancer patients, according to results presented by a University of Pittsburgh researcher at the 38th Annual Meeting of the American Society for Clinical Oncology (ASCO).

Brian Carr, MD, PhD, professor and director of the liver tumor service at the University of Pittsburgh Medical Center, evaluated safety and effectiveness of the novel treatment that emits beta rays via microscopic glass beads delivered by catheter directly into the liver through the hepatic artery.

"Hepatocellular carcinoma, a type of cancer that arises from liver...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-06-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry